APA (7th ed.) Citation

S, T., Y, W., M, T., L, S., J, D., K, L., . . . L, H. (2026). A STING-activating biomimetic mineralized nanovaccine triggers robust anti-tumor immunity. Cancer immunology, immunotherapy : CII, 75(4), . https://doi.org/10.1007/s00262-026-04320-3

Chicago Style (17th ed.) Citation

S, Tuo, et al. "A STING-activating Biomimetic Mineralized Nanovaccine Triggers Robust Anti-tumor Immunity." Cancer Immunology, Immunotherapy : CII 75, no. 4 (2026). https://doi.org/10.1007/s00262-026-04320-3.

MLA (9th ed.) Citation

S, Tuo, et al. "A STING-activating Biomimetic Mineralized Nanovaccine Triggers Robust Anti-tumor Immunity." Cancer Immunology, Immunotherapy : CII, vol. 75, no. 4, 2026, https://doi.org/10.1007/s00262-026-04320-3.